ImmuCell Corporation Accounts Payable, Trade, Current
ImmuCell Corporation (ICCC) had Accounts Payable, Trade, Current of $892.78 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Accounts Payable and Accrued Liabilities, Current › Accounts Payable, Current
us-gaap:AccountsPayableTradeCurrent · last filed 2026-08-13
- 2026-06-30: Accounts Payable, Trade, Current $892.78K.
- 2026-03-31: Accounts Payable, Trade, Current $935.10K.
- 2025-12-31: Accounts Payable, Trade, Current $792.22K.
- 2025-09-30: Accounts Payable, Trade, Current $949.65K.
| Period end | Accounts Payable, Trade, Current |
|---|---|
| 2026-06-30 | $892.78K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $935.10K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $792.22K 10-Q · filed 2026-08-13 |
| 2025-09-30 | $949.65K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $884.85K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $960.11K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $934.88K 10-K · filed 2026-03-30 |
| 2024-09-30 | $876.84K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $436.98K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $725.62K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $874.56K 10-K · filed 2025-03-28 |
| 2023-09-30 | $773.03K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $796.30K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $734.21K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $726.74K 10-K · filed 2024-04-01 |
| 2022-09-30 | $680.76K 10-Q · filed 2022-11-21 |
| 2022-06-30 | $610.41K 10-Q/A · filed 2022-11-21 |
| 2022-03-31 | $595.90K 10-Q/A · filed 2022-11-21 |
| 2021-12-31 | $726.78K 10-K · filed 2023-03-29 |
| 2021-09-30 | $654.85K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $462.35K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $662.98K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $602.35K 10-K · filed 2022-03-30 |
| 2020-09-30 | $444.25K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $532.30K 10-Q · filed 2020-08-12 |
| 2020-03-31 | $171.41K 10-Q · filed 2020-05-13 |
| 2019-12-31 | $401.96K 10-K · filed 2021-03-30 |
| 2019-09-30 | $397.44K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $436.02K 10-Q · filed 2019-08-12 |
| 2019-03-31 | $618.65K 10-Q · filed 2019-05-13 |
| 2018-12-31 | $531.05K 10-K · filed 2020-03-27 |
| 2018-09-30 | $515.78K 10-Q · filed 2018-11-13 |
| 2018-06-30 | $395.58K 10-Q · filed 2018-08-13 |
| 2018-03-31 | $362.69K 10-Q · filed 2018-05-14 |
| 2017-12-31 | $580.46K 10-K · filed 2019-03-22 |
| 2017-09-30 | $300.17K 10-Q · filed 2017-11-13 |
| 2017-06-30 | $252.45K 10-Q · filed 2017-08-14 |
| 2017-03-31 | $316.51K 10-Q · filed 2017-05-11 |
| 2016-12-31 | $257.40K 10-K · filed 2018-03-29 |
| 2016-09-30 | $412.38K 10-Q · filed 2016-11-10 |
| 2016-06-30 | $233.44K 10-Q · filed 2016-08-11 |
| 2016-03-31 | $185.25K 10-Q · filed 2016-05-11 |
| 2015-12-31 | $199.10K 10-K · filed 2017-03-30 |
| 2015-09-30 | $178.54K 10-Q · filed 2015-11-12 |
| 2015-06-30 | $205.48K 10-Q · filed 2015-08-13 |
| 2015-03-31 | $203.97K 10-Q · filed 2015-05-12 |
| 2014-12-31 | $204.81K 10-K · filed 2016-03-25 |
| 2013-12-31 | $199.72K 10-K · filed 2015-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |